30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Panbela Therapeutics Inc (PBLA)

Track

Stock chart
Ticker: PBLA Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GOLDMAN SACHS GROUP INC
1 sale — total 51,741 USD
Sale 8 Nov 2023
Value US$2,252,306.97 | Price 460.60 | Shares 79,031
Buy 30 Jan 2023
Value US$726,195.22 | Price 404.84 | Shares 33,546
Buy 30 Jan 2023
Value US$0.00 | Price 0.00 | Shares 4,444
Buy 4 Oct 2022
Value US$0.00 | Price 0.00 | Shares 200,000
Buy 4 Oct 2022
Value US$0.00 | Price 0.00 | Shares 33,000
Buy 4 Oct 2022
Value US$0.00 | Price 0.00 | Shares 165,000
Buy 10 Sep 2020
Value US$2,737.10 | Price 2.74 | Shares 1,000
Buy 8 Sep 2020
Value US$573.75 | Price 2.55 | Shares 225
Buy 4 Sep 2020
Value US$62,158.00 | Price 2.51 | Shares 24,775
Buy 1 Sep 2020
Value US$0.00 | Price 0.00 | Shares 2,424
Buy 1 Sep 2020
Value US$0.00 | Price 0.00 | Shares 2,424
Buy 1 Sep 2020
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 1 Sep 2020
Value US$0.00 | Price 0.00 | Shares 2,424
Buy 5 Jun 2020
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 5 Jun 2020
Value US$0.00 | Price 0.00 | Shares 2,500
Buy 22 May 2020
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 20 Sep 2019
Value US$0.00 | Price 0.00 | Shares 30,000
Buy 20 Sep 2019
Value US$0.00 | Price 0.00 | Shares 7,142
Buy 30 Aug 2019
Value US$0.00 | Price 0.00 | Shares 30,000
Buy 30 Aug 2019
Value US$0.00 | Price 0.00 | Shares 1,428
Sale 16 Aug 2019
Value US$1,030,233.00 | Price 3.00 | Shares 343,411
Sale 15 Aug 2018
Value US$0.00 | Price 0.00 | Shares 47,025
Buy 16 May 2018
Value US$0.00 | Price 0.00 | Shares 5,000
Buy 16 May 2018
Value US$0.00 | Price 0.00 | Shares 1,000
Buy 20 Feb 2018
Value US$0.00 | Price 0.00 | Shares 3,000
Buy 20 Feb 2018
Value US$0.00 | Price 0.00 | Shares 5,000
Buy 20 Feb 2018
Value US$0.00 | Price 0.00 | Shares 1,000
Sale 14 Nov 2016
Value US$10,010.00 | Price 1.43 | Shares 7,000
Buy 24 Jun 2016
Value US$0.00 | Price 0.00 | Shares 50,000
Buy 24 Jun 2016
Value US$0.00 | Price 0.00 | Shares 50,000
Buy 24 Jun 2016
Value US$0.00 | Price 0.00 | Shares 100,000
Buy 24 Jun 2016
Value US$0.00 | Price 0.00 | Shares 30,000
Buy 24 Jun 2016
Value US$0.00 | Price 0.00 | Shares 35,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-13 2023-11-08 S Sale
2.5
GOLDMAN SACHS GROUP INC
Large shareholder
79,031 -2.2%
460.60
US$2,252,307 		79,031 -2.2% 460.60 US$2,252,307
2023-02-01 2023-01-30 B Purchase
3.2
Simpson Jennifer K.

President and CEO

Executive Director
33,546
404.84
US$726,195 		33,546 404.84 US$726,195
2023-02-01 2023-01-30 B Purchase
Horvath Susan

V.P. of Finance & CFO

Officer
52,382
269.54
US$880,705 		52,382 269.54 US$880,705
2022-10-06 2022-10-04 B Purchase
Schemel Donald Robert
Non-Executive Director Large shareholder
200,000
0.00
US$0 		200,000 0.00 US$0
2022-10-06 2022-10-04 B Purchase
Jacob Jeffrey E.
Non-Executive Director
33,000
0.00
US$0 		33,000 0.00 US$0
2022-10-06 2022-10-04 B Purchase
Cullen Michael T.
Non-Executive Director Large shareholder
165,000
0.00
US$0 		165,000 0.00 US$0
2020-09-14 2020-09-10 B Purchase
3.2
Simpson Jennifer K.

President and CEO

Executive Director
1,000 +41.3%
2.74
US$2,737 		1,000 +41.3% 2.74 US$2,737
2020-09-09 2020-09-08 B Purchase
3.6
Schaffer Paul W.
Non-Executive Director
225 +0.1%
2.55
US$574 		225 +0.1% 2.55 US$574
2020-09-09 2020-09-04 B Purchase
3.6
Schaffer Paul W.
Non-Executive Director
24,775 +18.4%
2.51
US$62,158 		24,775 +18.4% 2.51 US$62,158
2020-09-01 2020-09-01 B Purchase
Fratamico Arthur
Non-Executive Director
2,424
0.00
US$0 		2,424 0.00 US$0
2020-09-01 2020-09-01 B Purchase
3.2
Simpson Jennifer K.

President and CEO

Executive Director
2,424
0.00
US$0 		2,424 0.00 US$0
2020-09-01 2020-09-01 B Purchase
Cullen Michael T.

Exec. Chairman, Pres. & CEO

Executive Director Large shareholder
10,000
0.00
US$0 		10,000 0.00 US$0
2020-09-01 2020-09-01 B Purchase
Horvath Susan

V.P. of Finance & CFO

Officer
2,424
0.00
US$0 		2,424 0.00 US$0
2020-06-09 2020-06-05 B Purchase
3.6
Schaffer Paul W.
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2020-06-09 2020-06-05 B Purchase
Horvath Susan

V.P. of Finance & CFO

Officer
2,500
0.00
US$0 		2,500 0.00 US$0
2020-05-27 2020-05-22 B Purchase
Cullen Michael T.

Exec. Chairman, Pres. & CEO

Executive Director Large shareholder
10,000
0.00
US$0 		10,000 0.00 US$0
2019-09-24 2019-09-20 B Purchase
3.6
Schaffer Paul W.
30,000
0.00
US$0 		30,000 0.00 US$0
2019-09-24 2019-09-20 B Purchase
Gagnon Suzanne
7,142
0.00
US$0 		7,142 0.00 US$0
2019-09-04 2019-08-30 B Purchase
Cullen Michael T.

Exec. Chairman, Pres. & CEO

Executive Director Large shareholder
30,000
0.00
US$0 		30,000 0.00 US$0
2019-09-04 2019-08-30 B Purchase
Horvath Susan

V.P. of Finance & CFO
1,428
0.00
US$0 		1,428 0.00 US$0
2019-08-26 2019-08-16 S Sale GILBERTSON RYAN RANDALL Large shareholder
343,411 -61.8%
3.00
US$1,030,233 		343,411 -61.8% 3.00 US$1,030,233
2019-01-24 2018-08-15 S Sale
GILBERTSON RYAN RANDALL
Large shareholder
47,025
0.00
US$0 		47,025 0.00 US$0
2018-06-14 2018-05-16 B Purchase Schaffer Paul W.
5,000
0.00
US$0 		5,000 0.00 US$0
2018-06-14 2018-05-16 B Purchase KAYSEN DAVID B

President and CEO

Executive Director
1,000
0.00
US$0 		1,000 0.00 US$0
2018-02-22 2018-02-20 B Purchase MATHIESEN JEFFREY S Non-Executive Director
3,000
0.00
US$0 		3,000 0.00 US$0
2018-02-22 2018-02-20 B Purchase Cullen Michael T.

Executive Chairman

Executive Director Large shareholder
5,000
0.00
US$0 		5,000 0.00 US$0
2018-02-22 2018-02-20 B Purchase Kellen Scott

Chief Financial Officer

Officer
1,000
0.00
US$0 		1,000 0.00 US$0
2016-12-01 2016-11-14 S Sale Schemel Donald Robert Non-Executive Director Large shareholder
7,000 -0.2%
1.43
US$10,010 		7,000 -0.2% 1.43 US$10,010
2016-06-28 2016-06-24 B Purchase KAYSEN DAVID B

President and CEO

Executive Director
50,000
0.00
US$0 		50,000 0.00 US$0
2016-06-28 2016-06-24 B Purchase
Cullen Michael T.

Executive Chairman

Executive Director
50,000
0.00
US$0 		50,000 0.00 US$0
2016-06-28 2016-06-24 B Purchase Schaffer Paul W. Non-Executive Director
100,000
0.00
US$0 		100,000 0.00 US$0
2016-06-28 2016-06-24 B Purchase Gagnon Suzanne Non-Executive Director
30,000
0.00
US$0 		30,000 0.00 US$0
2016-06-28 2016-06-24 B Purchase Kellen Scott

Chief Financial Officer

Officer
35,000
0.00
US$0 		35,000 0.00 US$0
Explore more

More insider trading research around Panbela Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America